These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 9698095)
1. Lack of evidence of kappa2-selective activation of G-proteins: kappa opioid receptor stimulation of [35S] GTPgammaS binding in guinea pig brain. Childers SR; Xiao R; Vogt L; Sim LJ Biochem Pharmacol; 1998 Jul; 56(1):113-20. PubMed ID: 9698095 [TBL] [Abstract][Full Text] [Related]
2. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain. Sim LJ; Childers SR J Comp Neurol; 1997 Oct; 386(4):562-72. PubMed ID: 9378852 [TBL] [Abstract][Full Text] [Related]
3. Mu and kappa1 opioid-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in cynomolgus monkey brain. Sim-Selley LJ; Daunais JB; Porrino LJ; Childers SR Neuroscience; 1999; 94(2):651-62. PubMed ID: 10579225 [TBL] [Abstract][Full Text] [Related]
4. Direct evidence for the up-regulation of spinal micro-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse. Narita M; Khotib J; Mizoguchi H; Suzuki M; Ozaki S; Yajima Y; Tseng LF; Suzuki T Eur J Neurosci; 2003 Nov; 18(9):2498-504. PubMed ID: 14622150 [TBL] [Abstract][Full Text] [Related]
5. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys. Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881 [TBL] [Abstract][Full Text] [Related]
6. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice. Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238 [TBL] [Abstract][Full Text] [Related]
7. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands. Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330 [TBL] [Abstract][Full Text] [Related]
8. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception. Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076 [TBL] [Abstract][Full Text] [Related]
9. Regional differences in mu and kappa opioid receptor G-protein activation in brain in male and female prairie voles. Martin TJ; Sexton T; Kim SA; Severino AL; Peters CM; Young LJ; Childers SR Neuroscience; 2015 Dec; 311():422-9. PubMed ID: 26523979 [TBL] [Abstract][Full Text] [Related]
10. 5-Hydroxytryptamine1A and 5-hydroxytryptamine1B receptors stimulate [35S]guanosine-5'-O-(3-thio)triphosphate binding to rodent brain sections as visualized by in vitro autoradiography. Waeber C; Moskowitz MA Mol Pharmacol; 1997 Oct; 52(4):623-31. PubMed ID: 9380025 [TBL] [Abstract][Full Text] [Related]
11. Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry. Narita M; Mizoguchi H; Oji DE; Dun NJ; Hwang BH; Nagase H; Tseng LF Br J Pharmacol; 1999 Nov; 128(6):1300-6. PubMed ID: 10578145 [TBL] [Abstract][Full Text] [Related]
12. Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig. Wang YJ; Rasakham K; Huang P; Chudnovskaya D; Cowan A; Liu-Chen LY J Pharmacol Exp Ther; 2011 Nov; 339(2):438-50. PubMed ID: 21841040 [TBL] [Abstract][Full Text] [Related]
13. Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptors. Sim LJ; Liu Q; Childers SR; Selley DE J Neurochem; 1998 Apr; 70(4):1567-76. PubMed ID: 9523574 [TBL] [Abstract][Full Text] [Related]
14. Receptor-mediated activation of G-proteins by kappa opioid agonists in frog (Rana esculenta) brain membranes. Rottmann M; Fábián G; Spicher K; Offermanns S; Szücs M Brain Res Bull; 1998 Mar; 45(5):467-74. PubMed ID: 9570716 [TBL] [Abstract][Full Text] [Related]
15. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors. Olianas MC; Concas D; Onali P Br J Pharmacol; 2006 Feb; 147(4):360-70. PubMed ID: 16402046 [TBL] [Abstract][Full Text] [Related]
16. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding. Sim LJ; Selley DE; Childers SR Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7242-6. PubMed ID: 7638174 [TBL] [Abstract][Full Text] [Related]
17. Activation of G-proteins in the mouse pons/medulla by beta-endorphin is mediated by the stimulation of mu- and putative epsilon-receptors. Mizoguchi H; Narita M; Nagase H; Tseng LF Life Sci; 2000 Oct; 67(22):2733-43. PubMed ID: 11105989 [TBL] [Abstract][Full Text] [Related]
18. kappa-opioid agonist stimulated regional distribution of [(35)S]GTPgammas binding in butorphanol continuously infused rat. Park Y; Jang CG; Ho IK; Ko KH Brain Res Bull; 2000 May; 52(1):17-20. PubMed ID: 10779697 [TBL] [Abstract][Full Text] [Related]
19. Autoradiographic distribution of mu-, delta- and kappa 1-opioid stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in human frontal cortex and cerebellum. Platzer S; Winkler A; Schadrack J; Dworzak D; Tölle TR; Zieglgänsberger W; Spanagel R Neurosci Lett; 2000 Apr; 283(3):213-6. PubMed ID: 10754225 [TBL] [Abstract][Full Text] [Related]
20. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors. Zhao GM; Qian X; Schiller PW; Szeto HH J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]